3rd Quarter - Report

COLLEGE OF AMERICAN PATHOLOGISTS for COLLEGE OF AMERICAN PATHOLOGISTS

Firm
Client
Income
—
Expenses
$141,488
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR2389/S1302 - Resident Physician Shortage Reduction Act S2333 - Public Health Workforce Loan Repayment Act Health Workforce Resilience Act S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act CLIA Waiver PREVENT Pandemics Act CURES 2.0 To prevent across-the-board direct spending cuts Cytotechnologist labor rates Remote digital telepathology S 1000/HR 2377 SALSA S 2140 - Patient Eligibility Restoration Act HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs. HR 1202/S 704 - REDI Act HR 2761 - SPARC act HR 2764/S1229 - Green New Deal for Health HR 3248 - Diagnostic Lab Testing Transparency Act H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 Student loan repayment for FPs HR 4527 - HEALTH DATA Act Primary Care and Health Workforce Expansion Act S 1994 Counting Veterans Cancer Act HR 4875 Doctors in our Borders Act HR 2474 - Strengthening Medicare for Patients and Providers Act S.2140 - Patent Eligibility Restoration Act of 2023

LobbyistCovered position, as disclosed
HANNAH BURRISS New —
DARREN FENWICK —
MICHAEL LOUIS GIULIANI —
MICHAEL HURLBUT New —
JOHN SCOTT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4942 (118th), H.R. 2764 (118th), H.R. 2389 (118th), H.R. 2761 (118th), H.R. 1202 (118th), H.R. 977 (118th), S. 2140 (118th), H.R. 2474 (118th), H.R. 4875 (118th), H.R. 3561 (118th), H.R. 4527 (118th), H.R. 3248 (118th), H.R. 2377 (118th)

Medicare/Medicaid MMM

Issues relating to surprise medical bills Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Verifying Accurate Leading-Edge IVCT Development (VALID) Act Advocating for relief from cuts to evaluation and management codes within Medicare Issues relating to the debt limit Issues relating to site-neutral payments Issue relating to artificial intelligence Issues relating to combatting fentanyl crisis Issues relating to Medicare coverage pathways Researching Long Covid Fees paid on electronically submitting to insurers Issues relating to the Clinical Laboratory Fee Schedule

LobbyistCovered position, as disclosed
HANNAH BURRISS New —
DARREN FENWICK —
MICHAEL LOUIS GIULIANI —
MICHAEL HURLBUT New —
JOHN SCOTT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.